Servier has wrapped up its previously announced acquisition of Symphogen, a Danish antibody discovery company, for an undisclosed price. The French pharma company signed the deal in April 2020 with a bid to ramp up its antibody capabilities while ensuring that its own antibody discovery and early-development platform is completely leveraged. Through the acquisition, Servier will […]
Servier acquisition of Symphogen : French pharma company Servier has agreed to acquire Danish antibody discovery company Symphogen, for an undisclosed price to boost its antibody capabilities while ensuring that its own antibody discovery and early-development platform is fully leveraged. As part of the deal, Servier will get access to Symphogen’s oncology and immune-oncology pipeline […]